Burden of disease due to amphetamines, cannabis, cocaine, and opioid use disorders in South America, 1990–2019: a systematic analysis of the Global Burden of Disease Study 2019-Reference-Cited by-同舟云学术

Burden of disease due to amphetamines, cannabis, cocaine, and opioid use disorders in South America, 1990–2019: a systematic analysis of the Global Burden of Disease Study 2019

Published:2023-02 Issue:2 Volume:10 Page:85-97
ISSN:2215-0366
Container-title:The Lancet Psychiatry
language:en
Short-container-title:The Lancet Psychiatry

Author:

Castaldelli-Maia João M,Wang Yuan-Pang,Brunoni Andre R,Faro Andre,Guimarães Rafael A,Lucchetti Giancarlo,Martorell Miquel,Moreira Rafael S,Pacheco-Barrios Kevin,Rodriguez Jefferson A B,Roever Leonardo,Silva Diego A S,Tovani-Palone Marcos R,Valdez Pascual R,Zimmermann Ivan R,Culbreth Garland T,Hay Simon I,Murray Christopher J L,Bensenor Isabela M

Funder

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Bill and Melinda Gates Foundation

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Publisher

Elsevier BV

Subject

Biological Psychiatry,Psychiatry and Mental health

Reference36 articles.

1. Global burden of disease attributable to illicit drug use and dependence: findings from the Global Burden of Disease Study 2010;Degenhardt;Lancet,2013

2. Non-medical use of opioid analgesics in contemporary Brazil: findings from the 2015 Brazilian National Household Survey on Substance Use;Krawczyk;Glob Public Health,2020

3. Changes in US lifetime heroin use and heroin use disorder: prevalence from the 2001–2002 to 2012–2013 National Epidemiologic Survey on Alcohol and Related Conditions;Martins;JAMA Psychiatry,2017